Increased leptin has been reported in subsets of cancer patients and demonstrated to stimulate proliferation of colon cancer cells, breast cancer cell migration, glioma migration and invasion, as well as the growth of cholangiocarcinoma cells in vitro. This evidence concerns the gene LEP and cancer.